Leaderboards/PARP inhibition in cancer therapy

PARP inhibition in cancer therapy

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Dana E. Rathkopf
Memorial Sloan Kettering Cancer Center
90
2
Xuyao Zhang
Fudan University
86
3
Patricia M. Harris
Q Therapeutics (United States)
84
4
Xiang‐Yang Ye
Hangzhou Normal University
63
5
Mahrous A. Abou-Salim
Al-Azhar University
62
6
Assem Barakat
King Saud University
58
7
Jérôme Alexandre
Université Paris Cité
56
8
Bing Xiong
Chinese Academy of Sciences
56
9
Suyin Feng
The First People’s Hospital of Lianyungang
56
10
Beicheng Sun
Anhui Medical University
53

Rising Stars Papers

1
Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer
Cell Death Discovery|2024
39 cit.
2
A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE
Cell Death and Disease|2024
22 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Mamdouh F. A. Mohamed
Sohag University
80
2
Yang Bai
Cornell University
78
3
Anton Safonov
Memorial Sloan Kettering Cancer Center
76
4
Waël Traboulsi
Georgetown University
76
5
Brant Gracia
The University of Texas MD Anderson Cancer Center
75
6
Ji Y. Son
The University of Texas MD Anderson Cancer Center
75
7
Qiyun Xiao
Sun Yat-sen University
73
8
Joan Kyula
Institute of Cancer Research
72
9
Florence Joly
Centre François Baclesse
72
10
Kailai Li
Zhujiang Hospital
71

Emerging Leaders Papers

1
Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers
Cell Reports|2024
10 cit.
2
Protein-Folding Chaperones Predict Structure-Function Relationships and Cancer Risk in <i>BRCA1</i> Mutation Carriers
bioRxiv (Cold Spring Harbor Laboratory)|2023
0 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Karim Fizazi
Université Paris-Saclay
99
2
Alan Ashworth
Breast Cancer Now
94
3
Barry S. Taylor
Memorial Sloan Kettering Cancer Center
87
4
Daniel Durocher
University of Toronto
84
5
Peter J. Park
Harvard University
84
6
Johann S. de Bono
Institute of Cancer Research
83
7
Jennifer L. Guerriero
Brigham and Women's Hospital
81
8
Zev A. Wainberg
University of California, Los Angeles
79
9
Mien‐Chie Hung
The University of Texas MD Anderson Cancer Center
77
10
José Baselga
Harvard University
73

All-Time Leaders Papers

1
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
New England Journal of Medicine|2015
2.2k cit.
2
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Nature Communications|2016
1.1k cit.
3
Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer
JNCI Journal of the National Cancer Institute|2007
876 cit.
4
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
New England Journal of Medicine|2020
760 cit.
5
The cardiac transcription factors Nkx2‐5 and GATA‐4 are mutual cofactors
The EMBO Journal|1997
671 cit.
6
A molecular portrait of microsatellite instability across multiple cancers
Nature Communications|2017
671 cit.
7
RETRACTED ARTICLE: A mechanism for the suppression of homologous recombination in G1 cells
Nature|2015
476 cit.
8
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
Nature Communications|2018
427 cit.
9
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
Nature|2018
415 cit.
10
Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer
Journal of Clinical Oncology|2005
409 cit.

Reagents for PARP inhibition in cancer therapy

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

HSP20 (E9Z1O) Rabbit Monoclonal Antibody

Cited in 11 papers
#16142$175
View Evidence →MedChemExpress

PI-103

Cited in 31 papers
#HY-10162
View Evidence →Cell Signaling Technology

Phospho-Histone H2A.X (Ser139) (D7T2V) Mouse Monoclonal Antibody

Cited in 13 papers
#80312$178
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

OAS1 (D1W3A) Rabbit Monoclonal Antibody

Cited in 9 papers
#14498$157
View Evidence →Cell Signaling Technology

Phospho-SGK1 (Ser78) (D36D11) Rabbit Monoclonal Antibody

Cited in 17 papers
#5599$178
View Evidence →Cell Signaling Technology

EGF Receptor (D38B1) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

Cited in 17 papers
#5588$465
View Evidence →

🌟 All-Time

Most validated

MedChemExpress

PI-103

Cited in 31 papers
#HY-10162
View Evidence →Cell Signaling Technology

SignalStain® Proliferation/Apoptosis IHC Sampler Kit

Cited in 22 papers
#8109$686
View Evidence →Proteintech

Geminin antibody

Cited in 18 papers
#10802-1-AP$449
View Evidence →